Novax

About Novax

Novax AB is the dedicated private equity arm of the Axel Johnson Group, the Swedish family-owned trading and services conglomerate controlled by the Antonia Ax:son Johnson family. Headquartered in Stockholm, Sweden, Novax was founded in 1999 as a long-term active ownership vehicle designed to identify, acquire and develop small-to-mid-cap Swedish growth companies that can become future pillars of the broader Axel Johnson portfolio. The firm operates as a corporate-anchored evergreen investment platform, drawing capital and patient ownership horizon from Axel Johnson rather than from third-party limited partners on a traditional fund-by-fund basis. Novax does not raise discrete vintage fund vehicles and deploys evergreen balance-sheet capital sourced from Axel Johnson and its broader Ax:son Johnson family ecosystem. As of December 2024, the portfolio comprised approximately 34 to 40 active platform and bolt-on holdings together employing more than 8,000 staff. Leadership rotated in late 2025 with Jonas Hedman appointed CEO and Anders Slettengren confirmed as Executive Chair, supported by a team of approximately 13 investment and operating professionals.

Investment thesis

Novax pursues an active-ownership growth-equity and buyout strategy focused on small and mid-sized Swedish and selectively French companies whose business models align with four secular thematic verticals: preventive health and active lifestyle, future-of-food and sustainable ingredients, technical security and smart-safety services, and digital retail infrastructure. The firm typically takes majority or significant-minority equity positions and explicitly avoids the time-bound exit pressure of conventional closed-end PE funds, allowing for indefinite hold periods. Tickets typically deploy in the mid-single-digit to low triple-digit million SEK range per platform, with capacity to top-up bolt-on acquisitions over many years. The capital base is anchored by Axel Johnson AB, supplemented in co-investment situations by Axfood and other Ax:son Johnson Group subsidiaries. Geographically the focus is overwhelmingly Sweden with a recent expansion into French-market opportunities. Value creation rests on buy-and-build platform consolidation, operational professionalisation drawing on the parent group industrial and retail know-how, and selective bolt-on M&A to scale platforms regionally.

Recent activity

Recent investment activity includes Gårdsfisk in sustainable aquaculture and food (March 2025 follow-on Series A), Volta Greentech in cleantech and agritech feed-additive (2024), NitroCapt in cleantech and agritech (2024), Proteinish in food and ingredients (2024) and JM Posner in food-service equipment (2023). The firm has continued to scale its Bond Health Group, Ingå Group, Aqua Dental and RCO platforms through follow-on commitments and add-on M&A. On the realisation side, recent exits include the partial divestment of Voyado in retail SaaS and customer-data platform (June 2025). Across its 25-year history Novax has executed approximately 26 realisations, with the active-portfolio cadence remaining weighted toward holding rather than exiting consistent with the evergreen mandate. Detailed buyer names and multiple data available on Pro at €29/month.